Understanding the relationship between genes and diseases is crucial for improving patient care. Gene-Disease Validity (GDV) scoring techniques continue to evolve

Ambry set out to determine the prevalence of cancer types in individuals with POT1 pathogenic variants (PVs) undergoing multigene panel testing (MGPT) for a broad…

rss feeds

OvaNext is a comprehensive genetic test for hereditary ovarian cancer designed to give you accurate and clinically meaningful information to help you offer personalized treatment,…

Ambry was founded with one goal– help patients and families. It is with this goal in mind that we design every test, accession every sample,…

For doctors who see patients with a strong family history of cancer, ordering genetic testing can provide invaluable information that can help prevent disease.